Pharmacoeconomics of amifostine in ovarian cancer

Seminars in Oncology

Volumn 26, Issue 2 SUPPL. 7, 1999, Pages 102-107

  Calhoun, E A ^a   Bennett, C L ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIFOSTINE;

ADVANCED CANCER; ARTICLE; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; DRUG EFFECT; HEALTH CARE COST; OVARY CANCER; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; RISK BENEFIT ANALYSIS;

AMIFOSTINE; ANTINEOPLASTIC AGENTS; CANADA; COST-BENEFIT ANALYSIS; CYTOPROTECTION; FEMALE; HUMANS; MODELS, ECONOMIC; OVARIAN NEOPLASMS; PROTECTIVE AGENTS; QUALITY-ADJUSTED LIFE YEARS; UNITED STATES;

EID: 0033033045     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)